Ebola patients in Democratic Republic of Congo begin receiving experimental treatments in a clinical trial targeting the rare Bundibugyo strain, which has killed more than 500 people there.
Patients with the Bundibugyo strain of Ebola have started receiving experimental treatments in a clinical trial aimed at improving care for the rare viral disease, which has killed more than 500 people in the Democratic Republic of Congo.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near Democratic Republic of Congo
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.